Clinical trials suggest virological/bacteriological burden is reduced with lactoferrin (for COVID-19 [61, 62] and HCV [63–65]) and with probiotic [for H. pylori [59] and HIV [54]) treatment; symptoms of these conditions were also reduced with nutritional intervention in some studies [55, 56, 58]. This evidence concerns the gene LTF and COVID-19.